MDxHealth (MDXH) Competitors $2.00 -0.14 (-6.54%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.02 +0.02 (+1.25%) As of 06/13/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDXH vs. XGN, SERA, OPGN, BDSX, BNR, ENZ, BGLC, ACON, NTRA, and LHShould you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include Exagen (XGN), Sera Prognostics (SERA), OpGen (OPGN), Biodesix (BDSX), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), BioNexus Gene Lab (BGLC), Aclarion (ACON), Natera (NTRA), and Laboratory Co. of America (LH). These companies are all part of the "medical laboratories" industry. MDxHealth vs. Its Competitors Exagen Sera Prognostics OpGen Biodesix Burning Rock Biotech Enzo Biochem BioNexus Gene Lab Aclarion Natera Laboratory Co. of America MDxHealth (NASDAQ:MDXH) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment. Does the MarketBeat Community favor MDXH or XGN? Exagen received 13 more outperform votes than MDxHealth when rated by MarketBeat users. Likewise, 62.22% of users gave Exagen an outperform vote while only 53.57% of users gave MDxHealth an outperform vote. CompanyUnderperformOutperformMDxHealthOutperform Votes1553.57% Underperform Votes1346.43% ExagenOutperform Votes2862.22% Underperform Votes1737.78% Do institutionals and insiders hold more shares of MDXH or XGN? 75.3% of Exagen shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by insiders. Comparatively, 12.6% of Exagen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is MDXH or XGN more profitable? Exagen has a net margin of -30.36% compared to MDxHealth's net margin of -49.52%. Exagen's return on equity of -92.58% beat MDxHealth's return on equity.Company Net Margins Return on Equity Return on Assets MDxHealth-49.52% -1,077.84% -28.82% Exagen -30.36%-92.58%-33.74% Which has more volatility & risk, MDXH or XGN? MDxHealth has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Exagen has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Does the media refer more to MDXH or XGN? In the previous week, Exagen had 3 more articles in the media than MDxHealth. MarketBeat recorded 5 mentions for Exagen and 2 mentions for MDxHealth. MDxHealth's average media sentiment score of 1.43 beat Exagen's score of 1.28 indicating that MDxHealth is being referred to more favorably in the media. Company Overall Sentiment MDxHealth Positive Exagen Positive Which has stronger valuation & earnings, MDXH or XGN? Exagen has lower revenue, but higher earnings than MDxHealth. Exagen is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMDxHealth$94.51M1.00-$43.10M-$1.15-1.74Exagen$56.72M2.67-$23.69M-$0.84-8.48 Do analysts rate MDXH or XGN? MDxHealth presently has a consensus price target of $6.50, indicating a potential upside of 225.00%. Exagen has a consensus price target of $7.50, indicating a potential upside of 5.34%. Given MDxHealth's higher possible upside, research analysts clearly believe MDxHealth is more favorable than Exagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MDxHealth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Exagen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryExagen beats MDxHealth on 12 of the 17 factors compared between the two stocks. Get MDxHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXH vs. The Competition Export to ExcelMetricMDxHealthMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$94.58M$3.20B$5.57B$8.51BDividend YieldN/A31.26%5.27%4.16%P/E Ratio-1.3215.3026.7819.65Price / Sales1.00179.60404.49152.18Price / CashN/A57.5638.2534.64Price / Book0.434.736.964.59Net Income-$43.10M-$22.21M$3.23B$248.23M7 Day Performance-3.38%2.30%-1.24%-1.07%1 Month Performance12.36%9.08%8.34%3.35%1 Year Performance-27.27%16.68%33.30%13.77% MDxHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXHMDxHealth3.2367 of 5 stars$2.00-6.5%$6.50+225.0%-29.1%$94.58M$94.51M-1.32300Positive NewsShort Interest ↓Gap DownHigh Trading VolumeXGNExagen3.3782 of 5 stars$7.17-1.1%$7.50+4.6%+263.3%$154.43M$56.72M-7.63220Positive NewsAnalyst RevisionSERASera Prognostics0.509 of 5 stars$1.50-3.2%N/A-78.7%$58.39M$115K-1.52120High Trading VolumeOPGNOpGenN/A$4.69-0.2%N/A+98.4%$47.22M$2.67M0.00100Positive NewsShort Interest ↓BDSXBiodesix3.4614 of 5 stars$0.29-4.4%$1.75+504.1%-81.9%$42.46M$74.46M-0.74220Short Interest ↑BNRBurning Rock Biotech0.8158 of 5 stars$3.02+4.1%N/A-50.3%$32.50M$515.82M-1.011,390Earnings ReportENZEnzo BiochemN/A$0.33-14.8%N/A-71.2%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBGLCBioNexus Gene Lab0.3991 of 5 stars$3.07-1.0%N/A-42.4%$5.52M$9.27M0.0030Gap UpACONAclarion2.2081 of 5 stars$7.13+3.8%$11,758.50+164,815.8%-99.7%$4.15M$54.60K0.007News CoverageShort Interest ↓Gap DownNTRANatera1.8716 of 5 stars$164.19+0.3%$184.63+12.4%+49.2%$22.42B$1.83B-93.293,020Positive NewsInsider TradeLHLaboratory Co. of America4.4122 of 5 stars$255.74+0.7%$272.92+6.7%+32.8%$21.41B$13.18B29.0075,500Positive NewsAnalyst ForecastInsider Trade Related Companies and Tools Related Companies XGN Competitors SERA Competitors OPGN Competitors BDSX Competitors BNR Competitors ENZ Competitors BGLC Competitors ACON Competitors NTRA Competitors LH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDXH) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Share MDxHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
